Stay updated on Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check22 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; there are no substantive changes to the study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page’s Locations section was updated to add numerous locations across the US, Australia, Canada, Europe and Asia, and several previously listed sites were removed.SummaryDifference1%

- Check73 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study. Revision: v3.3.2.SummaryDifference0.0%

- Check80 days agoChange DetectedThe funding-lapse operating-status notice on the page was removed, eliminating the informational banner about potential processing delays. This change does not affect the study details or accessibility of the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check87 days agoChange DetectedTaiwan site entry updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704'. This is a naming correction in the locations list to reflect the correct city name.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Epacadostat in Urothelial Carcinoma Clinical Trial page.